CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 128 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $27,000 | -32.5% | 15,186 | 0.0% | 0.00% | – |
Q1 2022 | $40,000 | -25.9% | 15,186 | +83.1% | 0.00% | – |
Q4 2020 | $54,000 | +575.0% | 8,292 | +761.1% | 0.00% | – |
Q2 2020 | $8,000 | -97.9% | 963 | -98.1% | 0.00% | -100.0% |
Q1 2020 | $380,000 | -7.8% | 49,600 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $412,000 | +9.3% | 49,600 | -3.1% | 0.00% | 0.0% |
Q3 2019 | $377,000 | -34.3% | 51,200 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $574,000 | +4.4% | 51,200 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $550,000 | -6.9% | 51,200 | +30.6% | 0.00% | 0.0% |
Q4 2018 | $591,000 | -18.5% | 39,200 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $725,000 | – | 39,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |